Wire · opportunities
iMDx Welcomes New Diagnostics Sales Leader to Prepare for Planned GraftAssureDx Launch
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 15 October 2026 · Fusion42 review
Insight Molecular Diagnostics has appointed Donnie Purto as Senior Vice President of Sales to lead commercialization of its transplant diagnostic product GraftAssureDx, which is pending FDA approval. The company plans to launch GraftAssureDx, an in vitro diagnostic kit for monitoring organ transplant rejection, following regulatory authorization.
This Wire brief sits within Fusion42's coverage of Diagnostics, and 2 sources have reported it.
◆ ◆ The Wire takeaway
You can enter transplant diagnostics now that this company is readying an FDA-cleared organ rejection test supported by strong sales leadership and key clinical partnerships. Start lining up kidney transplant centres to get ahead in this emerging medical niche.
◆ Coverage
2 sources · 14 Oct 2026
◆ Related on Wire
◆ Topics